Pluristem Therapeutics Inc.’s cell therapy products are designed to treat patients by stimulating their bodies’ own regenerative mechanisms

  • Clinical Programs

  • Products

  • Science & Technology

  • Benefits

    Technology platform for cell products, targeting treatment for a range of indications

  • Cell profiling expertise

    Deep understanding of the cell secretion profiles that generate therapeutic effects

  • Manufacturing facility

    Company-owned and operated GMP-certified manufacturing and research facilities


  • 24/06/2019Pluristem Completes Transition Period of Co-CEO Structure – Yaky Yanay appointed as Chief Executive Officer and Zami Aberman appointed as Executive Chairman of the Board

    Read More